Multicenter, Open-Label, Trial of Sarizotan in Parkinson Disease Patients with Levodopa-Induced Dyskinesias (the SPLENDID Study)

C. Warren Olanow, Philippe Damier, Christopher G. Goetz, Thomas Mueller, John Nutt, Olivier Rascol, Alexandru Serbanescu, Frieda Deckers, Hermann Russ

Research output: Contribution to journalArticle

154 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)58-62
Number of pages5
JournalClinical Neuropharmacology
Volume27
Issue number2
DOIs
StatePublished - Mar 2004

Fingerprint

Drug Dose Response Relationship
Drug-Induced Dyskinesia
Organic Chemicals
Antiparkinson Agents
Dyskinesias
Levodopa
Medical Records
Parkinson Disease
sarizotan

Keywords

  • Parkinson disease
  • Sarizotan
  • SPLENDID

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Multicenter, Open-Label, Trial of Sarizotan in Parkinson Disease Patients with Levodopa-Induced Dyskinesias (the SPLENDID Study). / Olanow, C. Warren; Damier, Philippe; Goetz, Christopher G.; Mueller, Thomas; Nutt, John; Rascol, Olivier; Serbanescu, Alexandru; Deckers, Frieda; Russ, Hermann.

In: Clinical Neuropharmacology, Vol. 27, No. 2, 03.2004, p. 58-62.

Research output: Contribution to journalArticle

Olanow, C. Warren ; Damier, Philippe ; Goetz, Christopher G. ; Mueller, Thomas ; Nutt, John ; Rascol, Olivier ; Serbanescu, Alexandru ; Deckers, Frieda ; Russ, Hermann. / Multicenter, Open-Label, Trial of Sarizotan in Parkinson Disease Patients with Levodopa-Induced Dyskinesias (the SPLENDID Study). In: Clinical Neuropharmacology. 2004 ; Vol. 27, No. 2. pp. 58-62.
@article{6e2f8e9dd18146ee82aee3f86706bac5,
title = "Multicenter, Open-Label, Trial of Sarizotan in Parkinson Disease Patients with Levodopa-Induced Dyskinesias (the SPLENDID Study)",
keywords = "Parkinson disease, Sarizotan, SPLENDID",
author = "Olanow, {C. Warren} and Philippe Damier and Goetz, {Christopher G.} and Thomas Mueller and John Nutt and Olivier Rascol and Alexandru Serbanescu and Frieda Deckers and Hermann Russ",
year = "2004",
month = "3",
doi = "10.1097/00002826-200403000-00003",
language = "English (US)",
volume = "27",
pages = "58--62",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Multicenter, Open-Label, Trial of Sarizotan in Parkinson Disease Patients with Levodopa-Induced Dyskinesias (the SPLENDID Study)

AU - Olanow, C. Warren

AU - Damier, Philippe

AU - Goetz, Christopher G.

AU - Mueller, Thomas

AU - Nutt, John

AU - Rascol, Olivier

AU - Serbanescu, Alexandru

AU - Deckers, Frieda

AU - Russ, Hermann

PY - 2004/3

Y1 - 2004/3

KW - Parkinson disease

KW - Sarizotan

KW - SPLENDID

UR - http://www.scopus.com/inward/record.url?scp=2342450729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342450729&partnerID=8YFLogxK

U2 - 10.1097/00002826-200403000-00003

DO - 10.1097/00002826-200403000-00003

M3 - Article

C2 - 15252265

AN - SCOPUS:2342450729

VL - 27

SP - 58

EP - 62

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 2

ER -